Ahorra 5 meses con 1 año de Premium al 35% dto ¡Lo quiero!
Role of the Microbiome in Reducing Risk of C diff Recurrence
  • 24/10/2017
  • 0
  • 0
  • 0

Role of the Microbiome in Reducing Risk of C diff Recurrence

Audio no disponible. Inténtalo más tarde.
  • Descargar
  • Compartir
  • Me gusta
  • Más
    • Escuchar en popup
    • Denunciar Contenido
Preparando para la descarga

Preparando audio para descarga.

Escucha patrocinada. El audio empezará en pocos segundos...

Escucha sin anuncios y sin esperas con iVoox Premium

Pruébalo Gratis

X

Descripción de Role of the Microbiome in Reducing Risk of C diff Recurrence

Join us with our guest Barbara McGovern, MD.
Since 2012 Dr. McGovern has been working within the pharmaceutical arena and currently is head of Medical Affairs at Seres Therapeutics, which is developing microbiome-based therapies. Their lead microbiome therapeutic drug is SER-109, which is being evaluated in a phase 3 clinical trial for recurrent Clostridium difficile infection. We will be discussing the role of the Microbiome in reducing the risk of C. diff. infection recurrence.

Mostrar Ocultar

internet radio health wellness talk Medical research microbiome microbiota VoiceAmerica Clostridium difficile CDiff C. diff. Spores and More Nancy Caralla Chandrabali Ghose Cdifficile Antibioti

Comentarios

Por decisión del propietario, no se aceptan comentarios anónimos. Registrate para comentarlo.

Más de Salud, hogar y consumo

VER TODOS